Highlights MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Market Closed - Canadian Securities Exchange Other stock markets 03:58:13 2024-07-16 pm EDT			5-day change	1st Jan Change
0.04 ^CAD	0.00%		0.00%	0.00%

Jul. 03	MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	CI
Mar. 21	MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	Jul. 02	CI
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 20	CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Mar. 04	CI
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.	23-10-24	CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-19	CI
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28	CI
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-05-05	CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-04-27	CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-27	CI
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	22-06-28	CI
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-23	CI
MYND Life Sciences Inc. Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins	22-06-01	CI
MYND Lifesciencs Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	22-03-31	CI
MYND Life Sciences Reports MoU to Buy Tidal Psychedelics	22-03-16	MT
MYND Lifesciencs Inc. entered into a non-binding memorandum of understanding to acquire Tidal Psychedelics.	22-03-15	CI
MYND Lifesciencs Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	22-02-27	CI
Mynd Life Sciences Announces Collaborative Research Agreement with the University of British Columbia	22-01-12	CI
MYND Lifesciencs Inc. Provides Update on Depression Gene Modulation Pathway Patent Application	21-12-15	CI
MYND Diagnostics Inc. Commences Clinical Research on Multiple Sclerosis Biomarker Test	21-11-18	CI
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer's Disease and Other Dementias	21-10-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Highlights

Filters